Marina Ruiz de Galarreta

8PUBLICATIONS
41CO-AUTHORS
Cancer cell biologyMedical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 19, 2025
Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy.

M Barcena-Varela, J Shang, I Mogno

|Dec 17, 2024
In Vivo Selection of S/MAR Sequences to Favour AAV Episomal Maintenance in Dividing Cells.

Andrea Llanos-Ardaiz, Aquilino Lantero, Leire Neri

|Nov 19, 2024
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma.

Katherine E Lindblad, Romain Donne, Ian Liebling

|Jun 23, 2022
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.

Andrew X Zhu, Alexander R Abbas, Marina Ruiz de Galarreta

|Jun 24, 2021
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.

Amanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta

|Apr 25, 2020
Mouse Models of Oncoimmunology in Hepatocellular Carcinoma.

Erin Bresnahan, Katherine E Lindblad, Marina Ruiz de Galarreta

Pageof 2

Frequent Collaborators

7 joint publications

Amaia Lujambio

2 joint publications

Marina Barcena-Varela

2 joint publications

Anthony Lozano

2 joint publications

Ian Liebling